The levels of β-thromboglobulin in female rheumatoid arthritis patients as activation criteria
- 170 Downloads
The activation of the platelets plays a key role in the formation of thrombosis. The variables such as mean platelet volume, platelet factor 4 and β-thromboglobulin have been used in the demonstration of the platelet activation. However, when the literature was reviewed, there was not found any study investigating the level of β-thromboglobulin in patients with rheumatoid arthritis. Our goal is to evaluate the β-thromboglobulin levels together with mean platelet volume in patients with arthritis. This study is a clinical study which has a control group that has been designed prospectively, and in this study, Rheumatology Outpatient Clinic follow-up patients with rheumatoid arthritis and healthy control group were studied. All patients and healthy volunteers were examined β-thromboglobulin and mean platelet volume. Twenty-two patients with rheumatoid arthritis and 21 healthy volunteers participated in the study. β-Thromboglobulin mean was found as 98.00 ± 60.49 ng/mL in rheumatoid arthritis group and it was 62.38 ± 30.41 ng/mL in healthy control group. The differences between these groups were significant in terms of the levels of β-thromboglobulin (p = 0.02). We found significant differences between the groups in terms of mean platelet volume (p = 0.049). In this study, the level of β-thromboglobulin was found significantly higher in patients with rheumatoid arthritis, which is a chronic inflammatory disease. This result could be an indicator, such as platelet activation in patients with rheumatoid arthritis, or it may be a helper marker in the follow-up and treatment of developing cardiovascular risk.
KeywordsRheumatoid arthritis Mean platelet volume β-Thromboglobulin Platelet function Atherosclerosis
Conflict of interest
We declare there is no conflict of interest.
- 2.Mevorach D, Paget SA (2000) Rheumatoid arthritis. In: Paget SA, Gibofsky A, Beary JF III (eds) Manuel of rheumatology and outpatient orthopedic disorders, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 192–229Google Scholar
- 9.Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, Sunder-Plassmann R (2002) Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 117(2):399–404PubMedCrossRefGoogle Scholar
- 10.Begg GS, Pepper DS, Chesterman CN, Morgan FJ (1978) Complete covalent structure of human β-thromboglobulin. Am Chem Soc 17(9):1739–1744Google Scholar
- 18.Warkentin TE, Kelton JG (2003) Platelet life cycle: quantitative disorders. In: Handin RI, Lux SE, Stossel TP (eds) Blood, principles and practise of hematology, 2nd edn. Lippincott Williams and Wilkins, Philadelphia, pp 984–1032Google Scholar